Pharmidex joins London Mayor Boris Johnson's trade mission to US
January 6, 2015

Boris Johnson is heading to the United States on a six-day trade mission aimed at bolstering London's science and technology industries.

Mr Boris Johnson’s US Trade Mission


Mr Boris Johnson, the Mayor of London has recently been in the US trying to attract investment for British businesses. Mr Johnson is using the US trade mission to promote London's TechCity - which supports the cluster of technology firms based in east London - and MedCity, which was launched last year to support life sciences.


He looked to visit Harvard University’s Stem Cell Institute (HSCI) in an attempt to bring together collaborations between London and Boston life sciences. Mr Johnson said “'The United States is a hugely important trading partner for London, offering massive opportunities for investment in this country and for businesses wanting to expand internationally. I want London to capitalise on the great relationships we have in Boston, New York City and Washington DC”.


In Boston and New York, the Mayor was joined by senior business figures from London's tech and life science sectors including Dr Mo Alavijeh of Pharmidex.


For more information please see: http://www.bbc.co.uk/news/uk-england-london-31161270


August 4, 2025
At Pharmidex , we go beyond exceptional science we deliver an experience built on trust, flexibility and deep collaboration. 📍 Scientist-Led from Start to Finish Your journey begins and ends with scientists, not sales teams. Our BD and Ops leads bring real scientific expertise to every conversation, ensuring smart, tailored study design and seamless execution. 🤝 Connected Teams, Coordinated Delivery From DMPK and bioanalysis to in vivo pharmacology, our integrated teams ensure smooth handoffs, eliminating delays and duplication. 🧪 Agile, High-Quality Science We adapt to evolving study needs across CNS, oncology, respiratory, autoimmune and rare diseases without compromising on quality. GLP and non-GLP studies are delivered on time, with transparency. 🧭 We’re Not Just a CRO, We’re Your Partner We offer guidance on model selection, regulatory strategy, data interpretation, and more. Your success is our mission. Let’s partner on your next breakthrough. 📧 Contact us today.
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩‍🔬 👨‍🔬 Welcome to the team, Gabrielle and Mohammed!
More Posts